Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-05-10 4:37 pm Sale | 13D | ACORDA THERAPEUTICS INC NE ACOR | DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 1,102,882 4.53% | -700,188 (-38.83%) | View |
| 2023-03-10 4:15 pm Sale | 13D | ACORDA THERAPEUTICS INC NE ACOR | DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 1,803,070 7.41% | -279,692 (-13.43%) | View |
| 2023-02-14 4:52 pm Sale | 13G | ACORDA THERAPEUTICS INC NE ACOR | CANYON CAPITAL ADVISORS LLC | 0 0% | -649,031 (Position Closed) | View |
| 2023-02-13 12:35 pm Purchase | 13G | ACORDA THERAPEUTICS INC NE ACOR | RENAISSANCE TECHNOLOGIES LLC | 868,892 3.57% | 154,736 (+21.67%) | View |
| 2023-01-23 4:30 pm Sale | 13D | ACORDA THERAPEUTICS INC NE ACOR | DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 2,082,762 8.56% | -320,541 (-13.34%) | View |
| 2022-06-10 4:24 pm Unchanged | 13G | ACORDA THERAPEUTICS INC NE ACOR | SOROS FUND MANAGEMENT LLC | 0 0% | 0 (Unchanged) | View |
| 2022-06-10 4:15 pm Purchase | 13D | ACORDA THERAPEUTICS INC NE ACOR | DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 2,403,303 9.9% | 2,403,303 (New Position) | View |
| 2022-02-14 4:56 pm Purchase | 13G | ACORDA THERAPEUTICS INC NE ACOR | CANYON CAPITAL ADVISORS LLC | 649,031 5.79% | 452,665 (+230.52%) | View |
| 2022-02-14 4:33 pm Purchase | 13G | ACORDA THERAPEUTICS INC NE ACOR | Point72 Asset Management L.P. | 464,276 4.1% | 464,276 (New Position) | View |
| 2022-02-14 10:16 am Sale | 13G | ACORDA THERAPEUTICS INC ACOR | UBS OCONNOR LLC | 0 0% | -5,323,234 (Position Closed) | View |
| 2022-02-11 2:20 pm Purchase | 13G | ACORDA THERAPEUTICS INC NE ACOR | RENAISSANCE TECHNOLOGIES LLC | 714,156 6.38% | 714,156 (New Position) | View |
| 2021-04-28 6:13 pm Sale | 13G | ACORDA THERAPEUTICS INC NE ACOR | CANYON CAPITAL ADVISORS LLC | 196,366 1.82% | -1,303,570 (-86.91%) | View |
| 2021-02-16 4:16 pm Purchase | 13G | ACORDA THERAPEUTICS INC NE ACOR | CANYON CAPITAL ADVISORS LLC | 1,499,936 13.91% | 1,499,936 (New Position) | View |
| 2021-02-16 3:55 pm Sale | 13G | ACORDA THERAPEUTICS INC ACOR | DIMENSIONAL FUND ADVISORS LP | 0 0% | -2,985,489 (Position Closed) | View |
| 2021-02-16 3:10 pm Sale | 13G | ACORDA THERAPEUTICS INC ACOR | Point72 Asset Management L.P. | 903,364 1.9% | -3,798,564 (-80.79%) | View |
| 2021-02-16 10:41 am Purchase | 13G | ACORDA THERAPEUTICS INC ACOR | UBS OCONNOR LLC | 5,323,234 9.99% | 5,323,234 (New Position) | View |
| 2021-02-12 07:46 am Sale | 13G | ACORDA THERAPEUTICS INC ACOR | SYMPHONY ASSET MANAGEMENT LLC | 0 0% | -4,633,427 (Position Closed) | View |
| 2021-02-11 10:24 am Purchase | 13G | ACORDA THERAPEUTICS INC ACOR | RENAISSANCE TECHNOLOGIES LLC | 4,085,285 8.52% | 228,035 (+5.91%) | View |
| 2021-02-10 2:49 pm Sale | 13G | ACORDA THERAPEUTICS INC NE ACOR | FEDERATED HERMES INC. FHI | 106,616 1.33% | -534,562 (-83.37%) | View |
| 2021-02-10 12:46 pm Purchase | 13G | ACORDA THERAPEUTICS INC NE ACOR | FEDERATED HERMES INC. FHI | 641,178 8.02% | 641,178 (New Position) | View |